NIH Extends CAP Deadline; Initiative Links SBIR Awardees With Investors to Help Commercialize Technology | GenomeWeb
NEW YORK (GenomeWeb News) - The National Institutes of Health extended the submission date for its Commercialization Assistance Program to Aug. 7.
 
The NIH SBIR CAP connects SBIR Phase II awardees with partners and investors to help move the products into the marketplace. The program is appropriate for researchers with clinical products looking for investments or alliances.
 
STTR awardees are not eligible to participate at this time.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.